BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10854070)

  • 1. Involvement of Ets transcription factors and targets in osteoblast differentiation and matrix mineralization.
    Vary CP; Li V; Raouf A; Kitching R; Kola I; Franceschi C; Venanzoni M; Seth A
    Exp Cell Res; 2000 May; 257(1):213-22. PubMed ID: 10854070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ets2 transcription factor inhibits mineralization and affects target gene expression during osteoblast maturation.
    Li V; Raouf A; Kitching R; Seth A
    In Vivo; 2004; 18(5):517-24. PubMed ID: 15523888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RING finger protein RNF11 is expressed in bone cells during osteogenesis and is regulated by Ets1.
    Gao Y; Ganss BW; Wang H; Kitching RE; Seth A
    Exp Cell Res; 2005 Mar; 304(1):127-35. PubMed ID: 15707580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
    Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
    Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
    J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro.
    Gordon JA; Tye CE; Sampaio AV; Underhill TM; Hunter GK; Goldberg HA
    Bone; 2007 Sep; 41(3):462-73. PubMed ID: 17572166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene array analysis of osteoblast differentiation.
    Beck GR; Zerler B; Moran E
    Cell Growth Differ; 2001 Feb; 12(2):61-83. PubMed ID: 11243467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
    Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
    J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids).
    Lian JB; Stein GS
    J Oral Implantol; 1993; 19(2):95-105; discussion 136-7. PubMed ID: 8246305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of the chromosome 21 transcription factor Ets2 in cell-seeded three-dimensional bone constructs.
    Turhani D; Watzinger E; Weissenböck M; Yerit K; Cvikl B; Ewers R; Thurnher D
    J Biomed Mater Res A; 2005 Jun; 73(4):445-55. PubMed ID: 15900611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures.
    Pockwinse SM; Wilming LG; Conlon DM; Stein GS; Lian JB
    J Cell Biochem; 1992 Jul; 49(3):310-23. PubMed ID: 1644867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter.
    Raouf A; Li V; Kola I; Watson DK; Seth A
    Oncogene; 2000 Apr; 19(15):1969-74. PubMed ID: 10773887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential.
    Wang D; Christensen K; Chawla K; Xiao G; Krebsbach PH; Franceschi RT
    J Bone Miner Res; 1999 Jun; 14(6):893-903. PubMed ID: 10352097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twisted gastrulation and chordin inhibit differentiation and mineralization in MC3T3-E1 osteoblast-like cells.
    Petryk A; Shimmi O; Jia X; Carlson AE; Tervonen L; Jarcho MP; O'connor MB; Gopalakrishnan R
    Bone; 2005 Apr; 36(4):617-26. PubMed ID: 15780974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.
    Ueno A; Miwa Y; Miyoshi K; Horiguchi T; Inoue H; Ruspita I; Abe K; Yamashita K; Hayashi E; Noma T
    J Cell Physiol; 2006 Nov; 209(2):322-32. PubMed ID: 16883596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sprouty genes are expressed in osteoblasts and inhibit fibroblast growth factor-mediated osteoblast responses.
    Yang X; Webster JB; Kovalenko D; Nadeau RJ; Zubanova O; Chen PY; Friesel R
    Calcif Tissue Int; 2006 Apr; 78(4):233-40. PubMed ID: 16604287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2010 Young Investigator Award winner: Therapeutic aprotinin stimulates osteoblast proliferation but inhibits differentiation and bone matrix mineralization.
    Schoenecker J; Mignemi N; Stutz C; Liu Q; Edwards J; Lynch C; Holt G; Schwartz H; Mencio G; Hamm H
    Spine (Phila Pa 1976); 2010 Apr; 35(9):1008-16. PubMed ID: 20407341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.